Publications

Sort by: Date | Author | Title

Böhme RA, Banellis L, Vejlø M, Allen MG, Fardo F. No evidence for a link between mental health symptoms and pain thresholds. Anxiety, Stress and Coping. 2026;39(1):101-117. Epub 2025 Jul 30. doi: 10.1080/10615806.2025.2534858
Galosi E, Sachau J, Baron R, Finnerup NB, Truini A. Reply to Chen and Yeh regarding clinical limitations of quantitative sensory testing in the diagnosis of small fiber neuropathy. Pain. 2026 Jan 1;167(1):243-244. doi: 10.1097/j.pain.0000000000003787
Kyng KJ, Møller AH, Skajaa T, Kerrn-Jespersen S, Bennedsgaard K, Rubak S et al. Improved Paediatric Procedural Competence and Knowledge After Training Using a Newborn Piglet Model. Acta paediatrica (Oslo, Norway : 1992). 2026 Jan;115(1):227-237. Epub 2025 Sept 17. doi: 10.1111/apa.70309
Leone CM, di Pietro G, di Stefano G, Quesada C, Salameh C, Perchet C et al. A multicentre randomized double-blind placebo-controlled study of lacosamide, pregabalin, and tapentadol on spinal pain biomarkers. Clinical Neurophysiology. 2026;2111591. Epub 2026. doi: 10.1016/j.clinph.2026.2111591
Pallesen LT, Pedersen AK, Sankaranarayanan I, Feldman-Goriachnik R, Ahlgreen OA, Pinheiro AM et al. Meteorin Resolves Nociceptive Hypersensitivity by Reducing Connexin-Mediated Coupling in Satellite Glial Cells. Glia. 2026 Feb;74(2):e70105. doi: 10.1002/glia.70105
Tong B, Farmer JR, Rosner J, Noonan VK, Cragg JJ, Griesdale D et al. Temporal trends in gabapentinoid use for the acute management of spinal cord injury: a retrospective cohort study. Spinal Cord. 2026. Epub 2026. doi: 10.1038/s41393-026-01172-7
Akerlund M, Baskozos G, Li W, Themistocleous AC, Pascal MMV, Rayner NW et al. Genetic associations of neuropathic pain and sensory profile in a deeply phenotyped neuropathy cohort. Pain. 2025 Jun 1;166(6):1354-1368. doi: 10.1097/j.pain.0000000000003463
Allmendinger F, Rosner J, Egger T, Scheuren PS, Hubli M. Nocebo Effect on Pain-Related Autonomic Responses in a State of Experimentally-Induced Sensitization. European journal of pain (London, England). 2025 May 1;29(5):e70029. doi: 10.1002/ejp.70029
Andréasson M, Paslawski W, Terkelsen AJ, Samuelsson K, Zetterberg H, Blennow K et al. Cutaneous nerve fiber pathology and function in Parkinson’s disease and atypical parkinsonism: a cohort study. npj Parkinson's Disease . 2025 Dec;11(1):170. doi: 10.1038/s41531-025-01030-y
Bitsch Poulsen M, Okdahl T, Buciek JH, Drewes AM, Karlsson P, Ahluwalia TS et al. Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes. BMJ Open. 2025 Oct 23;15(10):e101074. doi: 10.1136/bmjopen-2025-101074
Brask-Thomsen PK, Itani M, Karlsson P, Kristensen AG, Krøigård T, Jensen TS et al. Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study. Pain. 2025. Epub 2025. doi: 10.1097/j.pain.0000000000003649
Brock C, Andersen H, Alibegovic AC, Andersen ST, Andreasen LJ, Charles MH et al. Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations. Diabetes Research and Clinical Practice. 2025 Mar;221:112010. doi: 10.1016/j.diabres.2025.112010, 10.1016/j.diabres.2025.112010
Carmland ME, Kreutzfeldt MD, Brask-Thomsen PK, Jensen TS, Bach FW, Sindrup SH et al. Signs of hyperpathia in chronic peripheral neuropathic pain. European Journal of Pain. 2025 Mar;29(3):e4739. doi: 10.1002/ejp.4739
E. Hammer R, A. Omoniyi A, Richner M, Lezmi S, B. Vaegter C, Kalinichev M et al. The effect of recombinant botulinum neurotoxin A on neuropathic pain in the spared nerve injury mouse model. Journal of Neural Transmission. 2025 Dec;132:1779–1795. doi: 10.1007/s00702-025-02978-0
Emborg C, Kothari SF, Finnerup NB, Vase L. Minimizing placebo responses in clinical trials. In Benedetti F, Shaibani A, editors, Placebo Effects in Neurology. Vol. 213. Elsevier. 2025. p. 265-275. (Handbook of Clinical Neurology, Vol. 213). doi: 10.1016/B978-0-443-29884-4.00018-2
Galosi E, Litewczuk D, De Stefano G, Di Pietro G, Di Stefano G, Esposito N et al. Diagnostic accuracy of quantitative sensory testing for detecting small fiber impairment in polyneuropathy and diagnosing small fiber neuropathy. Pain. 2025. Epub 2025. doi: 10.1097/j.pain.0000000000003685
Gehr NL, Mortensen C, Stage TB, Pedersen MRV, Rafaelsen SR, Madsen JS et al. Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy. Cancer Chemotherapy and Pharmacology. 2025 Dec;95(1):53. doi: 10.1007/s00280-025-04773-w
Gormsen L, Fink P, Butler SH, Henningsen P, Loeser JD, Rief W et al. Can the pain field learn from the functional somatic disorder field? Pain. 2025 Dec;166(12):2689-2692. Epub 2025 Sept 21. doi: 10.1097/j.pain.0000000000003733
Hansen JS, Rasmussen PV, Finnerup NB, Svandsen KB. Patient's and researcher's perspectives on patient involvement in research in multiple sclerosis. Danish Medical Journal. 2025 Nov 19;72(12):A04250351. doi: 10.61409/A04250351

Search for a publication

Department:
Year between: and: